The aforementioned results have determined that highly expressed CXXC4 can inhibit the proliferation of gastric cancer cells and promote the activation of T cells, and CXXC4 can inhibit the expression of MIR100HG by inhibiting the phosphorylation of ELK1. The gene discussed is ELK1; the disease is gastric cancer.